Evidence map›Paper›PMID 34851965›Full record

ArticlePloS one2021

Aerosol tracer testing in Boeing 767 and 777 aircraft to simulate exposure potential of infectious aerosol such as SARS-CoV-2.

Sean M Kinahan, David B Silcott, Blake E Silcott, Ryan M Silcott, Peter J Silcott, Braden J Silcott, Steven L Distelhorst, Vicki L Herrera, Danielle N Rivera, Kevin K Crown and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. COVID-19 in the Airline Industry: The Good, the Bad, and the Necessary.New solutions : a journal of environmental and occupational health policy : NS · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sean M KinahanUniversity of Nebraska Medical Center, Omaha, Nebraska, United States of America.ORCID 0000-0001-8307-3771
David B SilcottS3I LLC, Reisterstown, Maryland, United States of America.ORCID 0000-0002-8179-824X
Blake E SilcottS3I LLC, Reisterstown, Maryland, United States of America.ORCID 0000-0002-2192-3491
Ryan M SilcottS3I LLC, Reisterstown, Maryland, United States of America.
Peter J SilcottS3I LLC, Reisterstown, Maryland, United States of America.
Braden J SilcottS3I LLC, Reisterstown, Maryland, United States of America.
Steven L DistelhorstNational Strategic Research Center, Omaha, Nebraska, United States of America.ORCID 0000-0002-1052-3089
Vicki L HerreraUniversity of Nebraska Medical Center, Omaha, Nebraska, United States of America.ORCID 0000-0002-0850-3783
Danielle N RiveraNational Strategic Research Center, Omaha, Nebraska, United States of America.
Kevin K CrownNational Strategic Research Center, Omaha, Nebraska, United States of America.ORCID 0000-0003-2817-278X
Gabriel A LuceroNational Strategic Research Center, Omaha, Nebraska, United States of America.
Joshua L SantarpiaUniversity of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Strategic Analysis (United States) · USUniversity of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has reintroduced questions regarding the potential risk of SARS-CoV-2 exposure amongst passengers on an aircraft. Quantifying risk with computational fluid dynamics models or contact tracing methods alone is challenging, as experimental results for inflight biological aerosols is lacking. Using fluorescent aerosol tracers and real time optical sensors, coupled with DNA-tagged tracers for aerosol deposition, we executed ground and inflight testing on Boeing 767 and 777 airframes. Analysis here represents tracer particles released from a simulated infected passenger, in multiple rows and seats, to determine the exposure risk via penetration into breathing zones in that row and numerous rows ahead and behind the index case. We present here conclusions from 118 releases of fluorescent tracer particles, with 40+ Instantaneous Biological Analyzer and Collector sensors placed in passenger breathing zones for real-time measurement of simulated virus particle penetration. Results from both airframes showed a minimum reduction of 99.54% of 1 μm aerosols from the index source to the breathing zone of a typical passenger seated directly next to the source. An average 99.97 to 99.98% reduction was measured for the breathing zones tested in the 767 and 777, respectively. Contamination of surfaces from aerosol sources was minimal, and DNA-tagged 3 μm tracer aerosol collection techniques agreed with fluorescent methodologies.

Indexed as

AircraftComputer SimulationCOVID-19DNAFluorescent DyesHumansMasksMicrospheresRespiratory Aerosols and DropletsSARS-CoV-2DNAFluorescent Dyes

Identifiers

PMID34851965
PMCPMC8635387
OpenAlexW3215624619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.